Tom Whitehouse, contributing editor at Global Corporate Venturing, hosted a breakout speciality sector session on health at the Global Corporate Venturing Symposium 2017
Douglas Trafelet, managing director of data provider PitchBook, began the session by presenting data on -venture -capital-backed investments in European healthcare and healthtech. This data showed seed stage dealflow increased last year despite a drop in total VC activity for healthcare after record highs for volume and value in 2015.
The highs of 2015 had been led by two large rounds for early-stage deals – $375m raised by Netherlands-based Acerta Pharma and $320m by UK-based Immunocore. Acerta’s traction prompted the…
